Prognostic values of serum neuronal biomarkers NSE and protein S-100 in acute period of severe hypoxic-ischemic encephalopathy in term infants
DOI:
https://doi.org/10.15587/2519-4798.2018.143413Keywords:
caspases, biomarkers, protein S-100, NSE, hypoxia, ischemia, reperfusion, hypothermia, encephalopathy, newbornsAbstract
It remains unclear if the serum concentrations of neuron-specific enolase (NSE) and protein S-100 correlate with severity and possible complications of hypoxic ischemic encephalopathy (HIE) as well as monitoring parameters of cerebral perfusion and central hemodynamics in term newborns.
The aim of research. To determine diagnostic and predictable values of NSE and protein S-100 in acute period of severe hypoxic-ischemic encephalopathy in neonates.
Materials and methods. Data of 89 term infants with Apgar score at birth of seven or less and Sarnat stage II-III was collected during ≤72 hours of life. The correlation between NSE, S-100 and Glasgow Coma Scale, seizures, confirmed by the aEEG, the unwanted development of neurological complications such as cerebral leukomalacia, and the short-term clinical results were analyzed.
Result. In acute period of HIE the concentration of serum neuronal biomarkers S-100 and NSE proteins substantially exceeds the reference values for the first hours after labor and exceeds the normal range until the 5th day of life. The dynamics of these data significantly changes during this period. Mostly diagnostically and prognostically significant the measurement of biomarkers was on the 3rd day of treatment, immediately after the end of the therapeutic hypothermia, at the beginning of rewarming and brain reperfusion, when both indicators were most closely correlated with the assessment of the GCS: NSE (r=-0.3; p=0.002 ) and S-100 (r=-0.3; p=0.003). The value of S-100 on day 1 correlating with the following unwanted development of leukomalacia is above 1.8 μg/L (p=0.002), which is more than 3 times higher from the reference level of 0.51 μg/L given by Simon-Pimmel J. (2017) for term newborns.
Conclusion. The evaluation of the serum concentrations of protein S-100 and neuron-specific enolase in the acute period of hypoxic ischemic encephalopathy in the term newborns has a significant diagnostic and predictable value and correlates with the severity and short-term clinical results of HIE
References
- Wyckoff, M. H., Aziz, K., Escobedo, M. B., Kapadia, V. S., Kattwinkel, J., Perlman, J. M. et. al. (2015). Part 13: Neonatal Resuscitation: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation, 132 (18), 543–560. doi: http://doi.org/10.1161/cir.0000000000000267
- Tagin, M., Abdel-Hady, H., Rahman, S., Azzopardi, D. V., Gunn, A. J. (2015). Neuroprotection for Perinatal Hypoxic Ischemic Encephalopathy in Low- and Middle-Income Countries. The Journal of Pediatrics, 167 (1), 25–28. doi: http://doi.org/10.1016/j.jpeds.2015.02.056
- Chiang, M.-C., Ashraf, Q. M., Ara, J., Mishra, O. P., Delivoria-Papadopoulos, M. (2007). Mechanism of caspase-3 activation during hypoxia in the cerebral cortex of newborn piglets. Neuroscience Letters, 421 (1), 67–71. doi: http://doi.org/10.1016/j.neulet.2007.05.024
- Kaur, C., Rathnasamy, G., Ling, E.-A. (2013). Roles of Activated Microglia in Hypoxia Induced Neuroinflammation in the Developing Brain and the Retina. Journal of Neuroimmune Pharmacology, 8 (1), 66–78. doi: http://doi.org/10.1007/s11481-012-9347-2
- Glass, H. C. (2014). Neonatal seizures: advances in mechanisms and management. Clinics in Perinatology, 41 (1), 177–190. doi: http://doi.org/10.1016/j.clp.2013.10.004
- Gerner, G. J., Burton, V. J., Poretti, A., Bosemani, T., Cristofalo, E., Tekes, A. et. al. (2015). Transfontanellar duplex brain ultrasonography resistive indices as a prognostic tool in neonatal hypoxic-ischemic encephalopathy before and after treatment with therapeutic hypothermia. Journal of Perinatology, 36 (3), 202–206. doi: http://doi.org/10.1038/jp.2015.169
- Chalak, L. F., Sánchez, P. J., Adams-Huet, B., Laptook, A. R., Heyne, R. J., Rosenfeld, C. R. (2014). Biomarkers for Severity of Neonatal Hypoxic-Ischemic Encephalopathy and Outcomes in Newborns Receiving Hypothermia Therapy. The Journal of Pediatrics, 164 (3), 468–474. doi: http://doi.org/10.1016/j.jpeds.2013.10.067
- Douglas-Escobar, M., Weiss, M. D. (2012). Biomarkers of hypoxic-ischemic encephalopathy in newborns. Frontiers in Neurology, 3, 144. doi: http://doi.org/10.3389/fneur.2012.00144
- Qian, J., Zhou, D., Wang, Y.-W. (2008). Umbilical artery blood S100β protein: a tool for the early identification of neonatal hypoxic-ischemic encephalopathy. European Journal of Pediatrics, 168 (1), 71–77. doi: http://doi.org/10.1007/s00431-008-0711-4
- Chiesa, C., Pellegrini, G., Panero, A., De Luca, T., Assumma, M., Signore, F., Pacifico, L. (2003). Umbilical cord interleukin-6 levels are elevated in term neonates with perinatal asphyxia. European Journal of Clinical Investigation, 33 (4), 352–358. doi: http://doi.org/10.1046/j.1365-2362.2003.01136.x
- Douglas-Escobar, M., Yang, C., Bennett, J., Shuster, J., Theriaque, D., Leibovici, A. et. al. (2010). A Pilot Study of Novel Biomarkers in Neonates With Hypoxic-Ischemic Encephalopathy. Pediatric Research, 68 (6), 531–536. doi: http://doi.org/10.1203/pdr.0b013e3181f85a03
- Massaro, A. N., Chang, T., Kadom, N., Tsuchida, T., Scafidi, J., Glass, P. et. al. (2012). Biomarkers of Brain Injury in Neonatal Encephalopathy Treated with Hypothermia. The Journal of Pediatrics, 161 (3), 434–440. doi: http://doi.org/10.1016/j.jpeds.2012.02.047
- Massaro, A. N., Chang, T., Baumgart, S., McCarter, R., Nelson, K. B., Glass, P. (2014). Biomarkers S100B and Neuron-Specific Enolase Predict Outcome in Hypothermia-Treated Encephalopathic Newborns. Pediatric Critical Care Medicine, 15 (7), 615–622. doi: http://doi.org/10.1097/pcc.0000000000000155
- Chaparro-Huerta, V., Flores-Soto, M. E., Merin Sigala, M. E., Barrera de León, J. C., Lemus-Varela, M. de L., Torres-Mendoza, B. M. de G., Beas-Zárate, C. (2017). Proinflammatory Cytokines, Enolase and S-100 as Early Biochemical Indicators of Hypoxic-Ischemic Encephalopathy Following Perinatal Asphyxia in Newborns. Pediatrics & Neonatology, 58 (1), 70–76. doi: http://doi.org/10.1016/j.pedneo.2016.05.001
- Beloborodova, N. V., Dmitriyeva, I. B., Chernevskaya, E. A. (2011). Diagnostic Value of S100B Protein in Critical Conditions. General Reanimatology, 7 (6), 72–76. doi: http://doi.org/10.15360/1813-9779-2011-6-72
- Abbasoglu, A., Sarialioglu, F., Yazici, N., Bayraktar, N., Haberal, A., Erbay, A. (2015). Serum Neuron-specific Enolase Levels in Preterm and Term Newborns and in Infants 1–3 Months of Age. Pediatrics & Neonatology, 56 (2), 114–119. doi: http://doi.org/10.1016/j.pedneo.2014.07.005
- Zaigham, M., Lundberg, F., Olofsson, P. (2017). Protein S100B in umbilical cord blood as a potential biomarker of hypoxic-ischemic encephalopathy in asphyxiated newborns. Early Human Development, 112, 48–53. doi: http://doi.org/10.1016/j.earlhumdev.2017.07.015
- Simon-Pimmel, J., Lorton, F., Masson, D., Bouvier, D., Hanf, M., Gras-Le Guen, C. (2017). Reference ranges for serum S100B neuroprotein specific to infants under four months of age. Clinical Biochemistry, 50 (18), 1056–1060. doi: http://doi.org/10.1016/j.clinbiochem.2017.08.014
- Elstad, M., Whitelaw, A., Thoresen, M. (2011). Cerebral Resistance Index is less predictive in hypothermic encephalopathic newborns. Acta Paediatrica, 100 (10), 1344–1349. doi: http://doi.org/10.1111/j.1651-2227.2011.02327.x
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2018 Denys Surkov
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our journal abides by the Creative Commons CC BY copyright rights and permissions for open access journals.
Authors, who are published in this journal, agree to the following conditions:
1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the journal under the terms of a Creative Commons CC BY, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this journal.
2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form in which it has been published by the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.